Skip to content
1887

Abstract

Urinary tract infections (UTI) are a major health and economic concern. Uropathogenic (UPEC) are the leading cause of UTI, and antibiotic-resistant UPEC are increasingly common. The microenvironment of the urinary tract is metabolically distinct, and there is growing interest in understanding the extent to which metabolism may influence UPEC infection and response to antibiotics, and how this varies between individuals. Diabetes, characterized in part by glycosuria, is a known risk factor for UTI and is associated with more severe infections. The role that glucose plays in driving UPEC evolution remains unclear. Through experimental evolution with a single UPEC isolate, we identified mutations in the RNA polymerase sigma factor associated with long-term glucose exposure. We found that the presence of the antibiotic gentamicin resulted in mutations in genes including , which encodes a potassium ion uptake system previously linked to aminoglycoside resistance, and in the autotransporter . Strikingly, these mutations were not present in populations exposed to a combination of both glucose and gentamicin. This suggests that glucose may influence the survival of mutants in gentamicin, providing new avenues for understanding the evolution and treatment of UPEC-mediated UTI in high-risk individuals.

Funding
This study was supported by the:
  • Biotechnology and Biological Sciences Research Council (Award BB/W020602/1)
    • Principal Award Recipient: AlanMcNally
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.001548
2025-03-28
2026-03-07

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/micro/171/3/mic001548.html?itemId=/content/journal/micro/10.1099/mic.0.001548&mimeType=html&fmt=ahah

References

  1. Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis 2001; 183 Suppl 1:S1–4 [View Article] [PubMed]
    [Google Scholar]
  2. Timm MR, Russell SK, Hultgren SJ. Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics. Nat Rev Microbiol 2025; 23:72–86 [View Article] [PubMed]
    [Google Scholar]
  3. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002; 113 Suppl 1A:5S–13S [View Article] [PubMed]
    [Google Scholar]
  4. Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol 2010; 7:653–660 [View Article] [PubMed]
    [Google Scholar]
  5. Werneburg GT. Catheter-associated urinary tract infections: current challenges and future prospects. Res Rep Urol 2022; 14:109–133 [View Article] [PubMed]
    [Google Scholar]
  6. Salari N, Karami MM, Bokaee S, Chaleshgar M, Shohaimi S et al. The prevalence of urinary tract infections in type 2 diabetic patients: a systematic review and meta-analysis. Eur J Med Res 2022; 27:20 [View Article] [PubMed]
    [Google Scholar]
  7. Whelan S, Lucey B, Finn K. Uropathogenic Escherichia coli (UPEC) associated urinary tract infections: the molecular basis for challenges to effective treatment. Microorganisms 2023; 11:2169 [View Article] [PubMed]
    [Google Scholar]
  8. Bonkat G, Cai T, Veeratterapillay R, Bruyère F, Bartoletti R et al. Management of Urosepsis in 2018. Eur Urol Focus 2019; 5:5–9 [View Article] [PubMed]
    [Google Scholar]
  9. Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol 2019; 11:1756287219832172 [View Article] [PubMed]
    [Google Scholar]
  10. Zagaglia C, Ammendolia MG, Maurizi L, Nicoletti M, Longhi C. Urinary tract infections caused by uropathogenic Escherichia coli strains—new strategies for an old pathogen. Microorganisms 2022; 10:1425 [View Article] [PubMed]
    [Google Scholar]
  11. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 2015; 13:269–284 [View Article] [PubMed]
    [Google Scholar]
  12. Bunduki GK, Heinz E, Phiri VS, Noah P, Feasey N et al. Virulence factors and antimicrobial resistance of uropathogenic Escherichia coli (UPEC) isolated from urinary tract infections: a systematic review and meta-analysis. BMC Infect Dis 2021; 21:753 [View Article] [PubMed]
    [Google Scholar]
  13. Bien J, Sokolova O, Bozko P. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol 2012; 2012:681473 [View Article] [PubMed]
    [Google Scholar]
  14. Mulvey MA. Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol 2002; 4:257–271 [View Article] [PubMed]
    [Google Scholar]
  15. Mann R, Mediati DG, Duggin IG, Harry EJ, Bottomley AL. Metabolic adaptations of uropathogenic E. coli in the urinary tract. Front Cell Infect Microbiol 2017; 7:241 [View Article] [PubMed]
    [Google Scholar]
  16. Chan CCY, Lewis IA. Role of metabolism in uropathogenic Escherichia coli. Trends Microbiol 2022; 30:1174–1204 [View Article] [PubMed]
    [Google Scholar]
  17. Cowart SL, Stachura ME. Glucosuria. In Walker HK, Hall WD, Hurst JW. eds Clinical Methods: The History, Physical, and Laboratory Examinations, 3rd Ed Boston: Butterworths; 1990
    [Google Scholar]
  18. Alteri CJ, Smith SN, Mobley HLT. Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog 2009; 5:e1000448 [View Article] [PubMed]
    [Google Scholar]
  19. Alteri CJ, Himpsl SD, Mobley HLT. Preferential use of central metabolism in vivo reveals a nutritional basis for polymicrobial infection. PLoS Pathog 2015; 11:e1004601 [View Article] [PubMed]
    [Google Scholar]
  20. Sintsova A, Frick-Cheng AE, Smith S, Pirani A, Subashchandrabose S et al. Genetically diverse uropathogenic Escherichia coli adopt a common transcriptional program in patients with UTIs. Elife 2019; 8:e49748 [View Article] [PubMed]
    [Google Scholar]
  21. Islam MJ, Bagale K, John PP, Kurtz Z, Kulkarni R. Glycosuria alters uropathogenic Escherichia coli global gene expression and virulence. mSphere 2022; 7:e0000422 [View Article] [PubMed]
    [Google Scholar]
  22. Nitzan O, Elias M, Chazan B, Saliba W. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Syndr Obes 2015; 8:129–136 [View Article] [PubMed]
    [Google Scholar]
  23. Colpan A, Johnston B, Porter S, Clabots C, Anway R et al. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrugresistant pathogen among US veterans. Clin Infect Dis: an official publication of the Infectious Diseases Society of America 2013; 57:1256–1265
    [Google Scholar]
  24. EUCAST Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST. European Society of Clinical Microbiology and Infectious Diseases; 2021
  25. Kolmogorov M, Yuan J, Lin Y, Pevzner PA. Assembly of long, error-prone reads using repeat graphs. Nat Biotechnol 2019; 37:540–546 [View Article] [PubMed]
    [Google Scholar]
  26. Wick RR, Holt KE. Polypolish: short-read polishing of long-read bacterial genome assemblies. PLoS Comput Biol 2022; 18:e1009802 [View Article] [PubMed]
    [Google Scholar]
  27. Schwengers O, Jelonek L, Dieckmann MA, Beyvers S, Blom J et al. Bakta: rapid and standardized annotation of bacterial genomes via alignment-free sequence identification. Microb Genom 2021; 7:000685 [View Article] [PubMed]
    [Google Scholar]
  28. Deatherage DE, Barrick JE. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. In Sun L, Shou W. eds Engineering and Analyzing Multicellular Systems: Methods and Protocols New York, NY: Springer; 2014 pp 165–188
    [Google Scholar]
  29. Jolley KA, Maiden MCJ. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 2010; 11:595 [View Article] [PubMed]
    [Google Scholar]
  30. Geerlings SE, Brouwer EC, Gaastra W, Verhoef J, Hoepelman AIM. Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals. J Med Microbiol 1999; 48:535–539 [View Article] [PubMed]
    [Google Scholar]
  31. Schlösser A, Meldorf M, Stumpe S, Bakker EP, Epstein W. TrkH and its homolog, TrkG, determine the specificity and kinetics of cation transport by the Trk system of Escherichia coli. J Bacteriol 1995; 177:1908–1910 [View Article] [PubMed]
    [Google Scholar]
  32. Lázár V, Pal Singh G, Spohn R, Nagy I, Horváth B et al. Bacterial evolution of antibiotic hypersensitivity. Mol Syst Biol 2013; 9:700 [View Article] [PubMed]
    [Google Scholar]
  33. Allsopp LP, Beloin C, Ulett GC, Valle J, Totsika M et al. Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073. Infect Immun 2012; 80:321–332 [View Article] [PubMed]
    [Google Scholar]
  34. Phan M-D, Peters KM, Sarkar S, Lukowski SW, Allsopp LP et al. The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone. PLoS Genet 2013; 9:e1003834 [View Article] [PubMed]
    [Google Scholar]
  35. Wells TJ, Tree JJ, Ulett GC, Schembri MA. Autotransporter proteins: novel targets at the bacterial cell surface. FEMS Microbiol Lett 2007; 274:163–172 [View Article] [PubMed]
    [Google Scholar]
  36. Wells TJ, Totsika M, Schembri MA. Autotransporters of Escherichia coli: a sequence-based characterization. Microbiology 2010; 156:2459–2469 [View Article] [PubMed]
    [Google Scholar]
  37. Bateman SL, Stapleton AE, Stamm WE, Hooton TM, Seed PC. The type 1 pili regulator gene fimX and pathogenicity island PAI-X as molecular markers of uropathogenic Escherichia coli. Microbiology 2013; 159:1606–1617 [View Article] [PubMed]
    [Google Scholar]
  38. Yadav M, Pundir S, Kumari R, Kumar A, Venugopal SJ et al. Virulence gene mutations as a differentiator of clinical phenotypes: insights from community-acquired uropathogenic Escherichia coli. Microbiology 2022; 168:001161 [View Article] [PubMed]
    [Google Scholar]
  39. Fischer D, Teich A, Neubauer P, Hengge-Aronis R. The general stress sigma factor sigmaS of Escherichia coli is induced during diauxic shift from glucose to lactose. J Bacteriol 1998; 180:6203–6206 [View Article] [PubMed]
    [Google Scholar]
  40. Cebrián G, Arroyo C, Condón S, Mañas P. Osmotolerance provided by the alternative sigma factors σB and rpoS to Staphylococcus aureus and Escherichia coli is solute dependent and does not result in an increased growth fitness in NaCl containing media. Int J Food Microbiol 2015; 214:83–90 [View Article] [PubMed]
    [Google Scholar]
  41. Valencia EY, de Moraes Gomes F, Ospino K, Spira B. RpoS role in antibiotic resistance, tolerance and persistence in E. coli natural isolates. BMC Microbiol 2024; 24:72 [View Article] [PubMed]
    [Google Scholar]
  42. Suryadarma P, Ojima Y, Fukuda Y, Akamatsu N, Taya M. The rpoS deficiency suppresses acetate accumulation in glucose-enriched culture of Escherichia coli under an aerobic condition. Front Chem Sci Eng 2012; 6:152–157 [View Article]
    [Google Scholar]
  43. Maciag A, Peano C, Pietrelli A, Egli T, De Bellis G et al. In vitro transcription profiling of the σS subunit of bacterial RNA polymerase: re-definition of the σS regulon and identification of σS-specific promoter sequence elements. Nucleic Acids Res 2011; 39:5338–5355 [View Article] [PubMed]
    [Google Scholar]
  44. Ueguchi C, Misonou N, Mizuno T. Negative control of rpoS expression by phosphoenolpyruvate: carbohydrate phosphotransferase system in Escherichia coli. J Bacteriol 2001; 183:520–527 [View Article] [PubMed]
    [Google Scholar]
  45. Carrilero L, Dunn SJ, Moran RA, McNally A, Brockhurst MA. Evolutionary responses to acquiring a multidrug resistance plasmid are dominated by metabolic functions across diverse Escherichia coli lineages. mSystems 2023; 8:e0071322 [View Article] [PubMed]
    [Google Scholar]
  46. Sastre-Dominguez J, DelaFuente J, Toribio-Celestino L, Herencias C, Herrador-Gómez P et al. Plasmid-encoded insertion sequences promote rapid adaptation in clinical enterobacteria. Nat Ecol Evol 2024; 8:2097–2112 [View Article]
    [Google Scholar]
  47. Duan X, Pan Y, Cai Z, Liu Y, Zhang Y et al. rpoS-mutation variants are selected in Pseudomonas aeruginosa biofilms under imipenem pressure. Cell Biosci 2021; 11:11–138 [View Article]
    [Google Scholar]
  48. Rosenberg EY, Ma D, Nikaido H. AcrD of Escherichia coli is an aminoglycoside efflux pump. J Bacteriol 2000; 182:1754–1756 [View Article] [PubMed]
    [Google Scholar]
  49. Aires JR, Nikaido H. Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli. J Bacteriol 2005; 187:1923–1929 [View Article]
    [Google Scholar]
  50. Alav I, Bavro VN, Blair JMA. Interchangeability of periplasmic adaptor proteins AcrA and AcrE in forming functional efflux pumps with AcrD in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 2021; 76:2558–2564 [View Article] [PubMed]
    [Google Scholar]
/content/journal/micro/10.1099/mic.0.001548
Loading
/content/journal/micro/10.1099/mic.0.001548
Loading

Data & Media loading...

Supplements

Supplementary material 1

EXCEL

Supplementary material 2

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error